GoodRx Holdings (GDRX) Change in Account Payables (2019 - 2026)
GoodRx Holdings' Change in Account Payables history spans 7 years, with the latest figure at -$10.5 million for Q4 2025.
- On a quarterly basis, Change in Account Payables fell 243.2% to -$10.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 125.94% increase, with the full-year FY2025 number at $4.1 million, up 125.94% from a year prior.
- Change in Account Payables hit -$10.5 million in Q4 2025 for GoodRx Holdings, down from $3.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for GDRX hit a ceiling of $25.5 million in Q3 2023 and a floor of -$15.6 million in Q2 2024.
- Historically, Change in Account Payables has averaged $182550.0 across 5 years, with a median of -$355000.0 in 2021.
- The widest YoY moves for Change in Account Payables: up 10030.77% in 2022, down 933.78% in 2022.
- Tracing GDRX's Change in Account Payables over 5 years: stood at -$115000.0 in 2021, then soared by 6306.09% to $7.1 million in 2022, then crashed by 134.76% to -$2.5 million in 2023, then skyrocketed by 396.17% to $7.3 million in 2024, then plummeted by 243.2% to -$10.5 million in 2025.
- Business Quant data shows Change in Account Payables for GDRX at -$10.5 million in Q4 2025, $3.5 million in Q3 2025, and $10.8 million in Q2 2025.